Literature DB >> 19361613

Genetic control of human brain transcript expression in Alzheimer disease.

Jennifer A Webster1, J Raphael Gibbs, Jennifer Clarke, Monika Ray, Weixiong Zhang, Peter Holmans, Kristen Rohrer, Alice Zhao, Lauren Marlowe, Mona Kaleem, Donald S McCorquodale, Cindy Cuello, Doris Leung, Leslie Bryden, Priti Nath, Victoria L Zismann, Keta Joshipura, Matthew J Huentelman, Diane Hu-Lince, Keith D Coon, David W Craig, John V Pearson, Christopher B Heward, Eric M Reiman, Dietrich Stephan, John Hardy, Amanda J Myers.   

Abstract

We recently surveyed the relationship between the human brain transcriptome and genome in a series of neuropathologically normal postmortem samples. We have now analyzed additional samples with a confirmed pathologic diagnosis of late-onset Alzheimer disease (LOAD; final n = 188 controls, 176 cases). Nine percent of the cortical transcripts that we analyzed had expression profiles correlated with their genotypes in the combined cohort, and approximately 5% of transcripts had SNP-transcript relationships that could distinguish LOAD samples. Two of these transcripts have been previously implicated in LOAD candidate-gene SNP-expression screens. This study shows how the relationship between common inherited genetic variants and brain transcript expression can be used in the study of human brain disorders. We suggest that studying the transcriptome as a quantitative endo-phenotype has greater power for discovering risk SNPs influencing expression than the use of discrete diagnostic categories such as presence or absence of disease.

Entities:  

Mesh:

Year:  2009        PMID: 19361613      PMCID: PMC2667989          DOI: 10.1016/j.ajhg.2009.03.011

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

1.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies.

Authors:  Daniel Falush; Matthew Stephens; Jonathan K Pritchard
Journal:  Genetics       Date:  2003-08       Impact factor: 4.562

3.  A genome-wide association study of global gene expression.

Authors:  Anna L Dixon; Liming Liang; Miriam F Moffatt; Wei Chen; Simon Heath; Kenny C C Wong; Jenny Taylor; Edward Burnett; Ivo Gut; Martin Farrall; G Mark Lathrop; Gonçalo R Abecasis; William O C Cookson
Journal:  Nat Genet       Date:  2007-09-16       Impact factor: 38.330

4.  Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues.

Authors:  Xijin Ge; Shogo Yamamoto; Shuichi Tsutsumi; Yutaka Midorikawa; Sigeo Ihara; San Ming Wang; Hiroyuki Aburatani
Journal:  Genomics       Date:  2005-08       Impact factor: 5.736

Review 5.  Exploiting naturally occurring DNA variation and molecular profiling data to dissect disease and drug response traits.

Authors:  Eric E Schadt
Journal:  Curr Opin Biotechnol       Date:  2005-10-24       Impact factor: 9.740

6.  The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease.

Authors:  J C Lambert; L Goumidi; F W Vrièze; B Frigard; J M Harris; A Cummings; J Coates; F Pasquier; D Cottel; M Gaillac; D St Clair; D M Mann; J Hardy; C L Lendon; P Amouyel; M C Chartier-Harlin
Journal:  Hum Mol Genet       Date:  2000-09-22       Impact factor: 6.150

7.  Identifying biological themes within lists of genes with EASE.

Authors:  Douglas A Hosack; Glynn Dennis; Brad T Sherman; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-09-11       Impact factor: 13.583

8.  A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging.

Authors:  Jeremy A Miller; Michael C Oldham; Daniel H Geschwind
Journal:  J Neurosci       Date:  2008-02-06       Impact factor: 6.167

9.  The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.

Authors:  Amanda J Myers; Alan M Pittman; Alice S Zhao; Kristen Rohrer; Mona Kaleem; Lauren Marlowe; Andrew Lees; Doris Leung; Ian G McKeith; Robert H Perry; Chris M Morris; John Q Trojanowski; Christopher Clark; Jason Karlawish; Steve Arnold; Mark S Forman; Vivianna Van Deerlin; Rohan de Silva; John Hardy
Journal:  Neurobiol Dis       Date:  2006-12-15       Impact factor: 5.996

10.  Using genetic markers to orient the edges in quantitative trait networks: the NEO software.

Authors:  Jason E Aten; Tova F Fuller; Aldons J Lusis; Steve Horvath
Journal:  BMC Syst Biol       Date:  2008-04-15
View more
  153 in total

1.  Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.

Authors:  Jason J Corneveaux; Amanda J Myers; April N Allen; Jeremy J Pruzin; Manuel Ramirez; Anzhelika Engel; Michael A Nalls; Kewei Chen; Wendy Lee; Kendria Chewning; Stephen E Villa; Hunsar B Meechoovet; Jill D Gerber; Danielle Frost; Hollie L Benson; Sean O'Reilly; Lori B Chibnik; Joshua M Shulman; Andrew B Singleton; David W Craig; Kendall R Van Keuren-Jensen; Travis Dunckley; David A Bennett; Philip L De Jager; Christopher Heward; John Hardy; Eric M Reiman; Matthew J Huentelman
Journal:  Hum Mol Genet       Date:  2010-06-09       Impact factor: 6.150

2.  Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways.

Authors:  Jeremy A Miller; Steve Horvath; Daniel H Geschwind
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-25       Impact factor: 11.205

3.  Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease.

Authors:  Nathan A Bihlmeyer; Emily Merrill; Yann Lambert; Gyan P Srivastava; Timothy W Clark; Bradley T Hyman; Sudeshna Das
Journal:  Alzheimers Dement       Date:  2019-03-29       Impact factor: 21.566

4.  Blood and brain gene expression trajectories mirror neuropathology and clinical deterioration in neurodegeneration.

Authors:  Yasser Iturria-Medina; Ahmed F Khan; Quadri Adewale; Amir H Shirazi
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501

5.  Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.

Authors:  Carlos Cruchaga; Petra Nowotny; John S K Kauwe; Perry G Ridge; Kevin Mayo; Sarah Bertelsen; Anthony Hinrichs; Anne M Fagan; David M Holtzman; John C Morris; Alison M Goate
Journal:  Arch Neurol       Date:  2011-08

6.  A common polymorphism near PER1 and the timing of human behavioral rhythms.

Authors:  Andrew S P Lim; Anne-Marie Chang; Joshua M Shulman; Towfique Raj; Lori B Chibnik; Sean W Cain; Katherine Rothamel; Christophe Benoist; Amanda J Myers; Charles A Czeisler; Aron S Buchman; David A Bennett; Jeanne F Duffy; Clifford B Saper; Philip L De Jager
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

7.  An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk.

Authors:  Shuquan Rao; Mahdi Ghani; Zhiyun Guo; Yuetiva Deming; Kesheng Wang; Rebecca Sims; Canquan Mao; Yao Yao; Carlos Cruchaga; Dietrich A Stephan; Ekaterina Rogaeva
Journal:  Neurobiol Aging       Date:  2018-01-03       Impact factor: 4.673

8.  Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis.

Authors:  Paul D Piehowski; Vladislav A Petyuk; Daniel J Orton; Fang Xie; Ronald J Moore; Manuel Ramirez-Restrepo; Anzhelika Engel; Andrew P Lieberman; Roger L Albin; David G Camp; Richard D Smith; Amanda J Myers
Journal:  J Proteome Res       Date:  2013-04-10       Impact factor: 4.466

9.  Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease.

Authors:  Margarita Giraldo; Francisco Lopera; Ashley L Siniard; Jason J Corneveaux; Isabelle Schrauwen; Julian Carvajal; Claudia Muñoz; Manuel Ramirez-Restrepo; Chris Gaiteri; Amanda J Myers; Richard J Caselli; Kenneth S Kosik; Eric M Reiman; Matthew J Huentelman
Journal:  Neurobiol Aging       Date:  2013-04-09       Impact factor: 4.673

10.  Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.

Authors: 
Journal:  Lancet       Date:  2013-02-28       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.